Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayside Health
ClinicalTrials.gov Identifier:
NCT00157144
First received: September 9, 2005
Last updated: March 6, 2014
Last verified: March 2014
  Purpose

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.


Condition
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Shock, Cardiogenic

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Bayside Health:

Study Start Date: October 2004
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving ECMO in Australia and New Zealand
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00157144

Locations
Australia, Victoria
Alfred Hospital
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: Vincent A Pellegrino, MBBS National Health and Medical Research Council, Australia
  More Information

No publications provided

Responsible Party: Bayside Health
ClinicalTrials.gov Identifier: NCT00157144     History of Changes
Other Study ID Numbers: 186/04
Study First Received: September 9, 2005
Last Updated: March 6, 2014
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
Lung Transplantation
Heart Transplantation

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Insufficiency
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Shock, Cardiogenic
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases
Lung Injury
Myocardial Infarction
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Shock
Pathologic Processes

ClinicalTrials.gov processed this record on September 16, 2014